Nearly 7 million Americans have been diagnosed with dementia, which slowly erodes memory, thinking skills and the ability to ...
Medical advances make pills to treat Alzheimer’s disease viable, though challenges remain in sharing gains globally ...
Summary: A new study has identified a biomarker, DTI-ALPS, which connects glymphatic system dysfunction to vascular dementia.
A study from the Keck School of Medicine of USC has tested a biomarker linked to vascular dementia across four separate ...
A simple digital health tool developed by Australian researchers could soon help predict the age of onset for early Alzheimer ...
The world’s largest study of proteins circulating the human body will begin in the UK this month, with the aim of pinpointing ...
A new study from the Keck School of Medicine of USC has tested a biomarker linked to vascular dementia across four separate ...
which looked at the drug in Alzheimer’s disease. But Axovant said it will continue to develop nelotanserin to treat hallucinations in patients with Parkinson’s disease dementia, and is ...
But that doesn't mean they have to come off the drugs ... a real concern about dementia – say, due to a family history – we might discuss alternative medicines and treatment options.
How Dementia Affects the Brain's Ability ... 2024 — Beta-blocker drugs -- commonly used to treat heart and blood pressure issues -- may slow the progression of Huntington's disease (HD ...
How Dementia Affects the Brain's Ability ... 2024 — Beta-blocker drugs -- commonly used to treat heart and blood pressure issues -- may slow the progression of Huntington's disease (HD ...